Phospholipid patterns of erythrocytes in schizophrenia: Relationships to symptomatology

Schizophrenia Research

Volumn 52, Issue 1-2, 2001, Pages 121-126

  Ponizovsky, A M ^a   Modai, I ^a,b   Nechamkin, Y ^a   Barshtein, G ^c   Ritsner, M S ^a,b   Yedgar, S ^c   Lecht, S ^d   Bergelson, L D ^d  

^a SHA'AR MENASHE MENTAL HEALTH CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c HEBREW UNIVERSITY   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Phosphatidylethanolamine; Positive and negative syndromes; Schizophrenia; Sphingomyelin

Indexed keywords

HALOPERIDOL; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPASE A2; POLYUNSATURATED FATTY ACID; SPHINGOMYELIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; LIPID COMPOSITION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ADULT; DEPRESSION; ERYTHROCYTES; FEMALE; HALLUCINATIONS; HUMANS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; PSYCHIATRIC STATUS RATING SCALES; REFERENCE VALUES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0035477446     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(00)00189-4     Document Type: Article

References (35)

1. 2 activity in serum of neuroleptic-naive psychiatric inpatients
2. Erythrocyte aggregation is selectively enhanced in negative syndrome of schizophrenia
3. A rapid method for total lipid extraction and purification
4. 2+-dependent translocation domain with homology to PKC and GAP
5. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia
6. Increased plasma phospholipase activity in schizophrenic patients; reduction after neuroleptic therapy
7. 2 activity in schizophrenia. A replication study
8. 2 in schizophrenia
9. A red cell membrane abnormalities in a subgroup of schizophrenic patients: Evidence for two diseases
10. The sphingomyelin cycle and the second messenger function of ceramide
11. 31P MRS in schizophrenia
12. Membrane abnormalities in schizophrenia
13. Red cell membrane fatty acids in schizophrenic patients with mainly positive or mainly negative symptoms
14. Schizophrenia is a membrane lipid disorder, which is expressed throughout the body
15. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia
16. 2 associated with schizophrenia
17. The positive and negative syndrome scale (PANSS) for schizophrenia
18. Erythrocyte membrane phospholipids in psychotic patients
19. Red cell phospholipids in schizophrenia
20. Alterations in erythrocyte aggregability in diabetics: The influence of plasmatic fibrinogen and phospholipids of the red blood cell membrane
21. 2(s); comparison of arachidonoyl-selective and -nonselective enzymes
22. Compensatory mechanisms in erythrocyte lipid in patients with atherosclerosis
23. 2 activity in schizophrenia and other psychiatric patients
24. 31P nuclear magnetic resonance spectroscopy study of neurodevelopment and schizophrenia
25. 2 gene
26. Brain and blood phospholipases in schizophrenia
27. 2
28. 2 activities in the brain of patients with schizophrenia
29. Ceramide and sphingomyelinases in the regulation of stress responses
30. An in vivo study of the prefrontal cortex of schizophrenia patients at different stages of illness via phosphorus magnetic resonance spectroscopy
31. The distribution of phospholipid fractions in the red cell membrane of schizophrenics
32. Defects in transmethylation and membrane lipids in schizophrenia
33. Modified Jungnickel's reagent for detecting phospholipids and other phosphorus compounds on thin-layer chromatograms